Vertex Pharmaceuticals Inc / Ma

Forvis Mazars Wealth Advisors, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

502

Value ($000)

228

Weight

0.0%

2020 Q2 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	228	0.0%	502	12/31/2025
2025 Q3	10/30/2025	232	0.0%	592	9/30/2025
2025 Q2	7/29/2025	712	0.0%	1,600	6/30/2025
2025 Q1	5/13/2025	702	0.0%	1,448	3/31/2025
2020 Q3	11/5/2020	230	0.0%	847	9/30/2020
2020 Q2	7/15/2020	236	0.0%	812	6/30/2020